6 min
Episode 8 (8 of 9): From a paradigm of degeneration/disease to one of healing/growth with Stem Cell and SVF autlogous treatment The Revolution of Regenerative Medicine- Stem Cell Surgery and SVF
-
- Medicina
The Revolution of Regenerative Medicine:
Dr. Laurence responds to a roundtable question from a post-myocardial infarction (heart attack) patient who previously was enrolled in an (IRB) approved human trial. The patient was not a responder to the direct placement of bone marrow-derived SVF into the heart. The patient is not certain whether her non-response was due to a placebo treatment or if there would have been a better way to deliver her own SVF (stem cells and extracellular factors). Dr. Laurence’s perspective is that the body normally effectively delivers oxygen and nutrition through the vascular network. He believes that if a direct placement of SVF/cells is indicated, that an additional vascular deployment would almost always be indicated.
This interaction begs the question: If efficacy can be demonstrated for healing diseased hearts, why would our paradigm not change to using similar approaches (along with healthy living) to treat all organs in a PREVENTIVE manner. Only time will tell if this strategy will meet the high standard of evidence-based medicine.
Please see the medical practice description and biography for Gregory Laurence, MD on podcast episode 1.
The Revolution of Regenerative Medicine:
Dr. Laurence responds to a roundtable question from a post-myocardial infarction (heart attack) patient who previously was enrolled in an (IRB) approved human trial. The patient was not a responder to the direct placement of bone marrow-derived SVF into the heart. The patient is not certain whether her non-response was due to a placebo treatment or if there would have been a better way to deliver her own SVF (stem cells and extracellular factors). Dr. Laurence’s perspective is that the body normally effectively delivers oxygen and nutrition through the vascular network. He believes that if a direct placement of SVF/cells is indicated, that an additional vascular deployment would almost always be indicated.
This interaction begs the question: If efficacy can be demonstrated for healing diseased hearts, why would our paradigm not change to using similar approaches (along with healthy living) to treat all organs in a PREVENTIVE manner. Only time will tell if this strategy will meet the high standard of evidence-based medicine.
Please see the medical practice description and biography for Gregory Laurence, MD on podcast episode 1.
6 min